Legal & General Group’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5K | Buy |
6,185
+633
| +11% | +$1.99K | ﹤0.01% | 3012 |
|
|
2025
Q1 | $17.4K | Buy |
5,552
+1,728
| +45% | +$5.43K | ﹤0.01% | 2987 |
|
|
2024
Q4 | $16.6K | Hold |
3,824
| – | – | ﹤0.01% | 3095 |
|
|
2024
Q3 | $10.2K | Hold |
3,824
| – | – | ﹤0.01% | 3266 |
|
|
2024
Q2 | $8.55K | Buy |
+3,824
| New | +$8.55K | ﹤0.01% | 3329 |
|
|
2022
Q2 | – | Sell |
-2,886
| Closed | -$7K | – | 3550 |
|
|
2022
Q1 | $7K | Hold |
2,886
| – | – | ﹤0.01% | 3466 |
|
|
2021
Q4 | $17K | Hold |
2,886
| – | – | ﹤0.01% | 3321 |
|
|
2021
Q3 | $19K | Hold |
2,886
| – | – | ﹤0.01% | 3292 |
|
|
2021
Q2 | $19K | Buy |
+2,886
| New | +$19K | ﹤0.01% | 3306 |
|
|
2017
Q2 | – | Sell |
-54
| Closed | -$4K | – | 3360 |
|
|
2017
Q1 | $4K | Hold |
54
| – | – | ﹤0.01% | 3245 |
|
|
2016
Q4 | $8K | Buy |
+54
| New | +$8K | ﹤0.01% | 3248 |
|